A Call for the Aggressive Treatment of Oligometastatic and Oligo-Recurrent Non-Small Cell Lung Cancer

Metastatic non-small cell lung cancer (NSCLC) carries a dismal prognosis. Clinical evidence suggests the existence of an intermediate, or oligometastatic, state when metastases are limited in number and/or location. In addition, following initial curative therapy, many patients present with limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Pretesh R., Yoo, David S., Niibe, Yuzuru, Urbanic, James J., Salama, Joseph K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483729/
https://www.ncbi.nlm.nih.gov/pubmed/23125927
http://dx.doi.org/10.1155/2012/480961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483729/
https://www.ncbi.nlm.nih.gov/pubmed/23125927
http://dx.doi.org/10.1155/2012/480961

Ejemplares similares